CNE000000NF8
CNE000000NF8
RENHE PHARMACY CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.41B EUR | 8.04B EUR | 7.91B EUR |
Enterprise Value | 3.67B EUR | 7.03B EUR | 5.14B EUR |
Valuation Multiples | |||
Trailing P/E | 18.89x | 28.64x | 25.98x |
Forward P/E | 8.67x | -- | -- |
Price to Sales | 2.03x | 2.85x | 2.95x |
Price to Book | 1.12x | 1.24x | 1.25x |
EV/Revenue | 1x | 2.49x | 1.92x |
EV/EBITDA | 5.38x | 10.97x | 7.98x |
Price to FCF (P/FCF) | 12.61x | 12.53x | 12.73x |
EV/FCF | 6.24x | 10.96x | 8.27x |
FCF Yield | 7.93% | 7.98% | 7.86% |